SGLT2 Inhibitor Use Rising in Diabetic Kidney Disease SGLT2 Inhibitor Use Rising in Diabetic Kidney Disease

' SGLT2 inhibitors are here to stay as a new standard of care for patients with diabetic kidney disease, ' said Dr Katherine Tuttle, a nephrologist at Providence Healthcare in Spokane, Washington.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news